Enzo Life Sciences Exendin-4 GLP-1 receptor agonist
Exendin-4 is a 39 aa polypeptide and incretin mimetic which was first isolated from Gila monster saliva. The synthetic form, Exenatide, is a glucagon like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II.
Research shows Exendin-4 is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying and reduction of food intake, often with body weight reduction or blunting of weight gain.
Phone: 02 4575 0309
AlphaThera oYo-Link Antibody Labeling Reagents
AlphaThera's oYo-Link Antibody Labeling Reagents enable site-specific antibody labelling....
Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers
The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...
RevMAb Biosciences histone family protein monoclonal antibodies
RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...